Shares of T1 Energy surged 10.1% to $5.44 after the company announced a 641 MW solar module supply agreement with Clearway Energy Group, one of the largest clean energy operators in the United States. The deal validates T1's bet on domestic manufacturing at a time when trade policy uncertainty is pushing U.S. solar developers to lock in American-made supply — but the stock's rally needs to be weighed against a company still burning cash and racing to finish building a critical factory.

  • A Big-Name Customer Signals the Strategy Is Working. Clearway's portfolio comprises approximately 13.9 GW of gross capacity across 27 states , and it recently signed 1.17 GW of long-term power purchase agreements with Google alone . Winning a contract from a buyer of that scale is a credibility stamp for T1, a company that only recently rebranded from FREYR Battery and pivoted into U.S. solar manufacturing . For investors, the deal suggests T1's product — traceable, American-made panels — can compete for major utility-scale projects, not just niche orders.

  • The Austin Factory Is the Linchpin — and It Isn't Done Yet. The modules will be assembled at T1's existing 5 GW Dallas plant, but the cells inside them must come from a new Austin facility still under construction. That plant's first 2.1 GW phase is expected to begin operations in Q1 2027 , and represents a $400–425 million investment . If Austin hits delays or cost overruns, T1 cannot deliver domestic-content modules as promised. The company aims to offer modules with more than 60% domestic content in 2027 — a threshold that matters for tax credits under current energy policy.

  • The Numbers Look Promising but the Company Is Still Losing Money. T1 currently carries trailing revenue of roughly $879 million, but a negative EBITDA of about $75 million, a gross margin of just 7.6%, and a debt-to-equity ratio of 122% . The 641 MW commitment accounts for roughly 13% of the Dallas facility's annual module capacity and 31% of the Austin cell plant's expected output . That is meaningful demand visibility but far from enough to fill either plant.

  • The Stock Has Momentum but the Price Target Gap Remains Wide. Analysts recently trimmed targets — Needham and Alliance Global cut theirs to $7, and Roth MKM issued a Buy . Even at $7, that implies roughly 29% upside from today's close, but T1 remains a high-volatility, early-stage manufacturer facing dilution and execution risk . The Clearway deal proves demand exists; the open question is whether T1 can build, finance, and deliver at scale before the cash runs out.